Quantum Biopharma Class B Subordinate Voting Shares
QNTM
19 hedge funds and large institutions have $1.74M invested in Quantum Biopharma Class B Subordinate Voting Shares in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.
450% more capital invested
Capital invested by funds: $316K → $1.74M (+$1.42M)
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
58% more funds holding
Funds holding: 12 → 19 (+7)
54% more call options, than puts
Call options by funds: $1.39M | Put options by funds: $903K
2.02% more ownership
Funds ownership: 0.58% → 2.59% (+2%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IEFM
IQ EQ Fund Management
Dublin 2,
Ireland
|
+$938K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$552K |
| 3 |
PCM
Penserra Capital Management
Orinda,
California
|
+$58.2K |
| 4 |
Jane Street
New York
|
+$35.1K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$32.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$72K |
| 2 |
Two Sigma Advisers
New York
|
-$26.8K |
| 3 |
FIA
FNY Investment Advisers
New York
|
-$10K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.4K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.12K |
QNTM Hedge Fund Activity: Q1 2021 in Review
19 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) for Q1 2021, worth a combined $1.74M — up 450% from $316K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new QNTM positions and 2 closed out — a net gain of 7 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was IQ EQ Fund Management, opening a new position worth an estimated $938K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $72K sold.
- 19 institutional investors held Quantum Biopharma Class B Subordinate Voting Shares (QNTM) as of Q1 2021, up from 12 in Q4 2020.
- Funds reported $1.74M of Quantum Biopharma Class B Subordinate Voting Shares stock for Q1 2021, up 450% quarter-over-quarter.
- 9 funds opened new Quantum Biopharma Class B Subordinate Voting Shares positions in Q1 2021 and 2 closed out, a net change of +7 holders.
- The largest Quantum Biopharma Class B Subordinate Voting Shares buyer in Q1 2021 was IQ EQ Fund Management, an estimated $938K added.
- The largest Quantum Biopharma Class B Subordinate Voting Shares seller in Q1 2021 was Renaissance Technologies, an estimated $72K sold.
Based on aggregated 13F filings for Q1 2021.